Saint Thomas Health

Nashville, Tennessee 37215

5 studies enrolling now · 18 studies all time

What they study most

Adult Solid Tumor, Aortic Stenosis, Calcific, Aortic Stenosis, Severe, Aortic Valve Insufficiency, Aortic Valve Stenosis, Atrial Fibrillation, Bradycardia, Cardiovascular Diseases, Heart Failure, Heart Transplant Rejection, Heart Valve Diseases, Ischemic Stroke; Ischemic Attack, Transient

Studies at this site

• ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves — Recruiting now
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis — Recruiting now
• ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve — Recruiting now
• A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
• The ENCIRCLE Trial — Recruiting now
• PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Surveillance HeartCare® Outcomes Registry — Running, not enrolling
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• TRISCEND II Pivotal Trial — Running, not enrolling
• ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis — Running, not enrolling
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• Tenecteplase in Stroke Patients Between 4.5 and 24 Hours — Completed
• INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study — Completed
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 — Paused